GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Trius Therapeutics, Inc. (TSRX) [hlAlert]

Rating:
Buy TSRX
up 70.37 %

Trius Therapeutics Inc. (TSRX) rated Buy with price target $11 by Global Hunter Securities

Posted on: Thursday,  May 26, 2011  8:25 AM ET by Global Hunter Securities

Global Hunter Securities rated Buy Trius Therapeutics, Inc. (NASDAQ: TSRX) on 05/26/2011, when the stock price was $8.00.
Since then, Trius Therapeutics, Inc. has gained 70.38% as of 09/11/2014's recent price of $13.63.
If you would have followed this Global Hunter Securities's recommendation on TSRX, you would have gained 70.37% of your investment in 1204 days.

Trius Therapeutics, Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of antibiotics for life threatening infections. The Company is developing torezolid phosphate, an intraveneous (IV) and oral antibiotic, for the treatment of serious gram-positive bacterial infections, initially for acute bacterial skin and skin structure infections (ABSSSI), and subsequently for other indications. The Company initiated its Phase III clinical program for torezolid phosphate for the treatment of ABSSSI in August 2010. In addition, the Company is developing antibiotics for gram-negative infections using its discovery platform under two contracts: one funded by the National Institute of Allergy and Infectious Diseases (NIAID), a part of the National Institutes of Health (NIH) and the other funded by the Defense Threat Reduction Agency (DTRA), a part of the Department of Defense.

Global Hunter Securities uses a disciplined quantitative and qualitative approach, our analysts are focused on covering small-cap companies with unique value and above average growth, primarily in the following sectors: Consumer, Energy, Healthcare, Industrial, Services and Technology. Additionally, Global Hunter Securities has analysts specifically focused on Special Situations and International opportunities. Global Hunter Securities' analysts maintain strong relationships and ongoing dialogue with management teams and industry professionals to ensure propitious access to information.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
5/26/2011 8:25 AM Buy
None
8.00 11.00
as of 12/30/2011
1 Week up  1.41 %
1 Month down  -3.63 %
3 Months up  13.49 %
1 YTD down  -10.62 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy